NOTCH1 and ovarian carcinoma: To further explore whether blocking Notch1 signaling could enhance cisplatin-mediated cell cytotoxicity in vivo, 5-week BALB/cAnN nude mice were subcutaneously injected with the chemoresistant ovarian cancer cell line ES-2.